Skip to content

Personalized Parkinson Project - Progressive Supranuclear Palsy cohort

Personalized Parkinson Project - Progressive Supranuclear Palsy cohort - PPP-PSP

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON49320
Enrollment
100
Registered
2021-02-11
Start date
2021-08-12
Completion date
Unknown
Last updated
2025-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Progressive Supranuclear Palsy

Interventions

&nbsp
Participants are wearing the Verily studywatch for 12 months&nbsp

Sponsors

Radboud Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria:  * Subject has possible or probable PSP, according to the established  international criteria defined by the Movement Disorders Society (MDS-PSP  criteria, Höglinger et al, 2017); diagnosis is confirmed based on by consensus  review of a videotaped neurological examination by two neurologists with deep  expertise in movement disorders. In case the experts still have doubts, the  treating physician will be asked to confirm the diagnosis and to send an MRI.  If that additional information does not take away doubts about the diagnosis,  the participant will be excluded.  * Subject is an adult, at least 50 years of age. * Subject can read and understand Dutch. * Subject has completed the CMO-approved Informed Consent. * Subject is willing, competent, and able to comply with all aspects of the  protocol. * Subject is able to walk at least 5 steps with or without minimal assistance  (ie, stabilization of 1 arm or use of a cane or walker). 

Exclusion criteria

Exclusion criteria:  * Subject has an additional condition or situation that, in the opinion of the  Investigator, makes the subject inappropriate for participation in the study. * For Study Watch: subject is allergic to nickel. 

Design outcomes

Primary

MeasureTime frame
The primary objective is to develop algorithms for the detection of disease progression in PSP patients in key clinical parameters: bradykinesia, gait, rising from a chair and falls, based on (1) sensor data obtained by means of passive monitoring during daily living; and (2) sensor data collected during the Virtual Motor Exam.

Secondary

MeasureTime frame
The second objective of this study is to create a longitudinal dataset describing the clinical and functional characteristics of a representative PSP cohort to allow researchers to investigate important unanswered questions in PSP.

Countries

Netherlands

Contacts

Public ContactMJ Meinders

Radboud Universitair Medisch Centrum

marjan.meinders@radboudumc.nl024-3615202

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)